Telomerase inhibitors and methods of their use

作者: Ryan Holcomb , Richard L. Tolman , Tsutomu Akama

DOI:

关键词:

摘要: Thiazolidinedione compounds, compositions, and methods of inhibiting telomerase activity in vitro treatment mediated conditions or diseases ex vivo are provided. The methods, compounds compositions the invention may be employed alone, combination with other pharmacologically active agents by activity, such as cancer. Also disclosed for assaying screening inhibitors activity.

参考文章(45)
Richard M. Hindley, 2,4-thiazolidinediones ,(1991)
Kanji Meguro, Takeshi Fujita, 2,4-thiazolidinediones ,(1984)
Tetsuya Nakamura, Koji Sawada, Wataru Matsumoto, Semi-conductive silicone rubber composition ,(2000)
Eiji Shirakawa, Hisashi Shinkai, Noboru Furukawa, Saizo Shibata, Itsuo Uchida, Shoji Onogi, Novel thiazolidinedione compound and use thereof. ,(1993)
Celia Ann Whitesitt, Jill Ann Panetta, Sandra Kay Sigmund, John Kevin Shadle, Richard Lee Simon, Jon Kevin Reel, Michael Leroy Phillips, Treatment of alzheimer's disease employing inhibitors of cathepsin d ,(1995)
Denis Ravel, Yolande Herve, Guillaume de Nanteuil, Jacques Duhault, 2,4-thiazolidinedione compounds ,(1993)
David T. Connor, Diane H. Boschelli, Catherine R. Kostlan, Thomas R. Belliotti, 2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents ,(1991)
Paul Charles Unangst, Wiaczeslaw Antin Cetenko, Roderick Joseph Sorenson, David Thomas Connor, Stephen Russell Stabler, Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents ,(1991)